Biocompatibles, a BTG International group company, is a leader in medical technology and operates in the field of interventional oncology using embolic and drug-device combination products.
We develop, manufacture and market implantable embolisation and drug-eluting beads that are used in more than 70 countries worldwide for the treatment of primary liver cancer (HCC), liver metastases from colorectal cancer, and other cancers.
We sell three of our products, , TM and , direct to specialist healthcare physicians in the US, and DC Bead®, DC BeadM1TM and Bead Block® through distributors in other countries.
We sell a number of approved interventional
medicine products in territories around the world.
Please click on the map to view information for products available in your country.